| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 265.59B | 288.69B | 305.51B | 297.95B | 320.71B |
| Gross Profit | 142.87B | 136.29B | 140.82B | 142.48B | 168.80B |
| EBITDA | 40.87B | 42.80B | 45.67B | 44.98B | 43.01B |
| Net Income | 30.56B | 32.30B | 35.82B | 35.27B | 34.38B |
Balance Sheet | |||||
| Total Assets | 7.83T | 7.81T | 7.67T | 7.26T | 6.95T |
| Cash, Cash Equivalents and Short-Term Investments | 1.05T | 1.08T | 721.11B | 634.86B | 625.80B |
| Total Debt | 1.12T | 1.03T | 790.82B | 753.77B | 785.27B |
| Total Liabilities | 7.13T | 7.16T | 7.04T | 6.64T | 6.37T |
| Stockholders Equity | 689.64B | 642.86B | 624.60B | 599.93B | 574.28B |
Cash Flow | |||||
| Free Cash Flow | -166.78B | -241.34B | 65.00B | 155.56B | 145.95B |
| Operating Cash Flow | -157.48B | -231.64B | 73.68B | 166.27B | 155.42B |
| Investing Cash Flow | 67.91B | -42.82B | 41.76B | -112.33B | 117.91B |
| Financing Cash Flow | 66.42B | 221.86B | -7.26B | -96.20B | -266.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.17T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$462.45B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$506.25B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
57 Neutral | HK$210.57B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% | |
57 Neutral | HK$649.95B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% | |
52 Neutral | HK$182.90B | 5.60 | 4.68% | 9.09% | -7.28% | -5.00% |